- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Palatin’s LeuTech begins phase III trials
Biopharmaceutical firm Palatin Technologies of Princeton, NJ, announced that it will begin multisite phase III trials next month for LeuTech, its radiopharmaceutical for infection imaging. LeuTech consists of a monoclonal antibody labeled with technetium
Biopharmaceutical firm Palatin Technologies of Princeton, NJ, announced that it will begin multisite phase III trials next month for LeuTech, its radiopharmaceutical for infection imaging. LeuTech consists of a monoclonal antibody labeled with technetium for imaging such infections as appendicitis and osteomyelitis. Palatin expects to complete phase III trials in the first part of 1999.
The firm is also working on peptide-based therapeutics and imaging agents such as PT5, a cancer therapeutic; PT11, an infection imaging agent based on the company's metal ion-induced distinctive array of structures (MIDAS) metallopeptide technology; and PT14, a therapeutic agent for sexual dysfunction.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.
